Rifaximin as a rare cause of rhabdomyolysis in cirrhosis

Autor:	Erin Armenia, Irene Soesilo, Alec B. Rezigh, Ting Li
Rok vydání:	2018
Předmět:	medicine.medical_specialty Cirrhosis Case Report Case Reports 030204 cardiovascular system & hematology adverse medication reaction 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine medicine 030212 general & internal medicine Intensive care medicine Hepatic encephalopathy business.industry cirrhosis General Medicine medicine.disease Rifaximin rifaximin Potential harm chemistry rhabdomyolysis Etiology business Rhabdomyolysis Medication list
Zdroj:	Clinical Case Reports
ISSN:	2050-0904
DOI:	10.1002/ccr3.1583
Popis:	Key Clinical Message Rifaximin has only been rarely reported to cause rhabdomyolysis. When physical and nonphysical etiologies have been excluded, thorough review of the patient’s medication list is necessary. In cirrhotics, the potential harm of rifaximin in treatment or prophylaxis of hepatic encephalopathy should be recognized.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d40671f862e7f8e44d3f3558bc2b2c0 https://doi.org/10.1002/ccr3.1583 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.